Rutherford TJ
No ORCID on file
· 5 papers in corpus
· active 2007-2022
Top journals
Frequent coauthors
- Schwartz PE 3
- Azodi M 2
- Cocco E 2
- Pecorelli S 2
- Buza N 2
- Bellone S 2
- Lockwood CJ 2
- Alessandro D. Santin 2
- Bellone M 2
- Silasi DA 2
2022
Oxidized regenerated cellulose (ORC) is an absorbable hemostat commonly used during gynecologic surgery. We present a case in which ORC was used in a patient undergoing posterior pelvic exenteration with ureteroneocystostomy for excision of…
2011
We evaluated the expression of tissue factor (TF) in ovarian cancer (EOC) and the potential of hI-con1, an antibody-like molecule targeting TF, as a novel form of therapy against chemotherapy-resistant ovarian disease. We studied the expres…
2010
BackgroundUterine serous papillary adenocarcinoma (USPC) is a highly aggressive variant of endometrial cancer. Human immuno-conjugate molecule (hI-con1) is an antibody-like molecule targeted against tissue factor (TF), composed of two human…
2010
ObjectiveEndometrial cancer (EC) is the most common gynecologic malignancy. Type I EC has a favorable prognosis, while type II ECs account for half of all treatment failures. Little knowledge of the biological differences is available to pr…
2007
PurposeThe insulin-like growth factor-II (IGF-II) gene has four promoters that produce distinct transcripts which vary by tissue type and developmental stage. Dysregulation of normal promoter usage has been shown to occur in cancer; DNA met…